A novel custom resequencing array for dilated cardiomyopathy

Genetics in Medicine

Volumn 12, Issue 5, 2010, Pages 268-278

  Zimmerman, Rebekah S ^a   Cox, Stephanie ^a   Lakdawala, Neal K ^b   Cirino, Allison ^b   Mancini Dinardo, Debora ^a   Clark, Eugene ^a   Leon, Annette ^a   Duffy, Elizabeth ^a   White, Emily ^a   Baxter, Samantha ^a   Alaamery, Manal ^a   Farwell, Lisa ^a   Weiss, Scott ^a   Seidman, Christine E ^c   Seidman, Jonathan G ^c   Ho, Carolyn Y ^b   Rehm, Heidi L ^a,b   Funke, Birgit H ^a,b,d  

^a LABORATORY FOR MOLECULAR MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Dilated cardiomyopathy; Genetic test; Locus heterogeneity; Resequencing array

Indexed keywords

ADULT; ALLELE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

CARDIOMYOPATHY, DILATED; FAMILY; FEMALE; GENETIC TESTING; HUMANS; MUTATION; PREGNANCY;

EID: 77952536025     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181d6f7c0     Document Type: Article

References (72)

1. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007;26:769-781.
2. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 2005;45:969-981.
3. Hershberger RE, Cowan J, Morales A, Siegfried JD. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertro-phic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2009;2:253-261.
4. Daehmlow S, Erdmann J, Knueppel T, et al. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun 2002;298:116-120.
5. Hershberger RE, Parks SB, Kushner JD, et al. Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci 2008;1:21-26.
6. Kamisago M, Sharma SD, DePalma SR, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000; 343:1688-1696.
7. Mogensen J, Murphy RT, Shaw T, et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyop-athy. J Am Coll Cardiol 2004;44:2033-2040.
8. Mohapatra B, Jimenez S, Lin JH, et al. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibro-elastosis. Mol Genet Metab 2003;80:207-215.
9. Moller DV, Andersen PS, Hedley P, et al. The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet 2009;17:1241-1249.
10. Shimizu M, Ino H, Yasuda T, et al. Gene mutations in adult Japanese patients with dilated cardiomyopathy. Circ J 2005;69:150-153.
11. Villard E, Duboscq-Bidot L, Charron P, et al. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J 2005;26:794-803.
12. Zeller R, Ivandic BT, Ehlermann P, et al. Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE. J Mol Med 2006;84:682-691.
13. Denning L, Anderson JA, Davis R, Gregg JP, Kuzdenyi J, Maselli RA. High throughput genetic analysis of congenital myasthenic syndromes using re-sequencing microarrays. PLoS One 2007;2:e918.
14. Fokstuen S, Lyle R, Munoz A, et al. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy. Hum Mutat 2008;29:879-885.
15. Mandal MN, Heckenlively JR, Burch T, et al. Sequencing arrays for screening multiple genes associated with early-onset human retinal degenerations on a high-throughput platform. Invest Ophthalmol Vis Sci 2005;46:3355-3362.
16. Waldmuller S, Muller M, Rackebrandt K, et al. Array-based resequencing assay for mutations causing hypertrophic cardiomyopathy. Clin Chem 2008; 54:682-687.
17. Zhou S, Kassauei K, Cutler DJ, et al. An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome. J Mol Diagn 2006;8:476-482.
18. Zwick ME, McAfee F, Cutler DJ, et al. Microarray-based resequencing of multiple Bacillus anthracis isolates. Genome Biol 2005;6:R10.
19. Kothiyal P, Cox S, Ebert J, Aronow BJ, Greinwald JH, Rehm HL. An overview of custom array sequencing. Curr Protoc Hum Genet 2009; Chapter 7:Unit 7.17.
20. Arimura T, Hayashi T, Terada H, et al. A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J Biol Chem 2004;279:6746-6752.
21. Vatta M, Mohapatra B, Jimenez S, et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003;42:2014-2027.
22. Hermida-Prieto M, Monserrat L, Castro-Beiras A, et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am J Cardiol 2004;94:50-54.
23. Parks SB, Kushner JD, Nauman D, et al. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardio-myopathy. Am Heart J 2008;156:161-169.
24. Perrot A, Hussein S, Ruppert V, et al. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomy-opathy. Basic Res Cardiol 2009;104:90-99.
25. Sebillon P, Bouchier C, Bidot LD, et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 2003;40:560-567.
26. Sylvius N, Bilinska ZT, Veinot JP, et al. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet 2005;42:639-647.
27. van Tintelen JP, Hofstra RM, Katerberg H, et al. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Am Heart J 2007;154:1130-1139.
28. D'Adamo P, Fassone L, Gedeon A, et al. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 1997;61:862-867.
29. Manilal S, Recan D, Sewry CA, et al. Mutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression. Hum Mol Genet 1998;7:855-864.
30. Sakata K, Shimizu M, Ino H, et al. High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene. Circulation 2005;111:3352-3358.
31. Talkop UA, Talvik I, Sonajalg M, et al. Early onset of cardiomyopathy in two brothers with X-linked Emery-Dreifuss muscular dystrophy. Neuromus-cul Disord 2002;12:878-881.
32. Emery AE. Emery-Dreifuss muscular dystrophy\a 40 year retrospective. Neuromuscul Disord 2000;10:228-232.
33. Goldfarb LG, Vicart P, Goebel HH, Dalakas MC. Desmin myopathy. Brain 2004;127(Pt 4):723-734.
34. Kostareva A, Gudkova A, Sjoberg G, et al. Desmin mutations in a St. Petersburg cohort of cardiomyopathies. Acta Myol 2006;25:109-115.
35. Li D, Tapscoft T, Gonzalez O, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999;100:461-464.
36. Taylor MR, Slavov D, Ku L, et al. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 2007;115:1244-1251.
37. Bos JM, Poley RN, Ny M, et al. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab 2006;88:78-85.
38. Geier C, Gehmlich K, Ehler E, et al. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum Mol Genet 2008;17: 2753-2765.
39. Knoll R, Hoshijima M, Hoffman HM, et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002;111:943-955.
40. Newman B, Cescon D, Woo A, et al. W4R variant in CSRP3 encoding muscle LIM protein in a patient with hypertrophic cardiomyopathy. Mol Genet Metab 2005;84:374-375.
41. Hayashi T, Arimura T, Itoh-Satoh M, et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 2004;44:2192-2201.
42. Olson TM, Illenberger S, Kishimoto NY, Huttelmaier S, Keating MT, Jockusch BM. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 2002;105:431-437.
43. Vasile VC, Will ML, Ommen SR, Edwards WD, Olson TM, Ackerman MJ. Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol Genet Metab 2006;87: 169-174.
44. Zemljic-Harpf AE, Miller JC, Henderson SA, et al. Cardiac-myocyte- specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy. Mol Cell Biol 2007;27:7522-7537.
45. Moreira ES, Wiltshire TJ, Faulkner G, et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet 2000;24:163-166.
46. Karkkainen S, Miettinen R, Tuomainen P, et al. A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy. J Mol Med 2003;81:795-800.
47. Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000;106:655-662.
48. Erdmann J, Hassfeld S, Kallisch H, Fleck E, Regitz-Zagrose V. Genetic variants in the promoter (g983GT) and coding region (A92T) of the human cardiotrophin-1 gene (CTF1) in patients with dilated cardiomyopathy. Hum Mutat 2000;16:448.
49. Bienengraeber M, Olson TM, Selivanov VA, et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet 2004;36:382-387.
50. Minoretti P, Falcone C, Aldeghi A, et al. A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction. Clin Chim Acta 2006; 370:124-128.
51. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardio-vasc Res 2008;77:659-666.
52. Li D, Parks SB, Kushner JD, et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet 2006;79: 1030-1039.
53. Knoll R, Postel R, Wang J, et al. Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardi-omyocytes and endothelial cells. Circulation 2007;116:515-525.
54. Cutler DJ, Zwick ME, Carrasquillo MM, et al. High-throughput variation detection and genotyping using microarrays. Genome Res 2001;11:1913-1925.
55. Lebet T, Chiles R, Hsu AP, Mansfield ES, Warrington JA, Puck JM. Mutations causing severe combined immunodeficiency: detection with a custom resequencing microarray. Genet Med 2008;10:575-585.
56. Hartmann A, Thieme M, Nanduri LK, et al. Validation of microarray-based resequencing of 93 worldwide mitochondrial genomes. Hum Mutat 2009; 30:115-122.
57. Kryukov GV, Pennacchio LA, Sunyaev SR. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet 2007;80:727-739.
58. Ionita-Laza I, Lange C, Laird NM. Estimating the number of unseen variants in the human genome. Proc Natl Acad Sci USA 2009;106:5008-5013.
59. Bar H, Strelkov SV, Sjoberg G, Aebi U, Herrmann H. The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation? J Struct Biol 2004;148:137-152.
60. Goudeau B, Rodrigues-Lima F, Fischer D, et al. Variable pathgenic potentials of mutations located in the desmin alpha-helical domain. Hum Mutat 2006;27:906-913.
61. Moulik M, Vatta M, Witt SH, et al. ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. J Am Coll Cardiol 2009;54:325-333.
62. Brauch KM, Karst ML, Herron KJ, et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol 2009;54:930-941.
63. Hassel D, Dahme T, Erdmann J, et al. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med 2009;15:1281-1288.
64. Sylvius N, Duboscq-Bidot L, Bouchier C, et al. Mutational analysis of the beta-and delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathy. Am J Med Genet A 2003;120A:8-12.
65. Carballo S, Robinson P, Otway R, et al. Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circ Res 2009;105:375-382.
66. Tesson F, Sylvius N, Pilotto A, et al. Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy. Eur Heart J 2000;21:1872-1876.
67. Taylor MR, Fain PR, Sinagra G, et al. Natural history of dilated cardiomy-opathy due to lamin A/C gene mutations. J Am Coll Cardiol 2003;41:771-780.
68. Arbustini E, Pilotto A, Grasso M, et al. Novel human pathological mutations. Gene symbol: LMNA. Disease: cardiomyopathy, dilated with conduction defects. Hum Genet 2009;125:350.
69. DeWitt MM, MacLeod HM, Soliven B, McNally EM. Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1396-1398.
70. Haghighi K, Kolokathis F, Gramolini AO, et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci USA 31 2006;103:1388-1393.
71. Haghighi K, Kolokathis F, Pater L, et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 200l;111:869-876.
72. Schmitt JP, Kamisago M, Asahi M, et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 2003;299:1410-1413.